Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Bladder Cancer |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Mortality and cancer incidence in perfluorooctanesulfonyl fluoride production
workers.
Am J Ind Med. 2024;67:321-333.
PubMed
Abstract available
RAS Family Gene Mutations, Clinicopathological Features, and Spread Patterns of
Inverted Urothelial Papilloma of the Bladder.
Am J Surg Pathol. 2024;48:458-464.
PubMed
Abstract available
Amplification-Free Analysis of Bladder Cancer MicroRNAs on Wrinkled Silica
Nanoparticles with DNA-Functionalized Quantum Dots.
Anal Chem. 2024 Mar 13. doi: 10.1021/acs.analchem.3c05204.
PubMed
Abstract available
Long-term survival after volatile or propofol general anesthesia for bladder
cancer surgery: a retrospective national registry cohort study.
Anesthesiology. 2024 Mar 11. doi: 10.1097/ALN.0000000000004969.
PubMed
Abstract available
Clinical analysis of small-cell carcinoma of the urinary bladder: A case report
and review of literature.
Asian J Surg. 2024;47:1602-1603.
PubMed
Securinine inhibits the tumor growth of human bladder cancer cells by suppressing
Wnt/beta-catenin signaling pathway and activating p38 and JNK signaling pathways.
Biochem Pharmacol. 2024 Mar 12:116125. doi: 10.1016/j.bcp.2024.116125.
PubMed
Abstract available
SRT1720 inhibits bladder cancer cell progression by impairing autophagic flux.
Biochem Pharmacol. 2024;222:116111.
PubMed
Abstract available
Dysregulation and antimetastatic function of circLRIG1 modulated by
miR-214-3p/LRIG1 axis in bladder carcinoma.
Biol Direct. 2024;19:20.
PubMed
Abstract available
The optimal number of induction chemotherapy cycles in clinically lymph
node-positive bladder cancer.
BJU Int. 2024 Mar 12. doi: 10.1111/bju.16319.
PubMed
Abstract available
The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial
in patients with bladder cancer.
BJU Int. 2024 Mar 12. doi: 10.1111/bju.16325.
PubMed
Abstract available
Patient experience of bladder cancer: A data linkage study.
BJUI Compass. 2024;5:382-388.
PubMed
Abstract available
Identification of BACH1-IT2-miR-4786-Siglec-15 immune suppressive axis in bladder
cancer.
BMC Cancer. 2024;24:328.
PubMed
Abstract available
The mechanism of PFK-1 in the occurrence and development of bladder cancer by
regulating ZEB1 lactylation.
BMC Urol. 2024;24:59.
PubMed
Abstract available
Survival and clinicopathological significance of B7-H3 in bladder cancer: a
systematic review and meta-analysis.
BMC Urol. 2024;24:57.
PubMed
Abstract available
Development of a prognostic model for long-term survival of young patients with
bladder cancer: a retrospective analysis of the SEER Database.
BMJ Open. 2024;14:e080092.
PubMed
Abstract available
Efficacy and tolerability of bacillus Calmette-Guerin strain Russia for the
treatment of non-muscle-invasive bladder cancer: Analysis of a prospective
registry.
Can Urol Assoc J. 2024 Mar 1. doi: 10.5489/cuaj.8552.
PubMed
Abstract available
Unraveling a hidden player in lymphovascular invasion in bladder cancer.
Cancer Cell. 2024 Mar 6:S1535-6108(24)00051-5. doi: 10.1016/j.ccell.2024.
PubMed
Abstract available
The mechanism of resistance to CDK4/6 inhibition and novel combination therapy
with RNR inhibition for chemo-resistant bladder cancer.
Cancer Commun (Lond). 2024 Mar 11. doi: 10.1002/cac2.12532.
PubMed
LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and
redirecting M2-like macrophage polarisation in bladder cancer.
Cancer Lett. 2024 Mar 8:216807. doi: 10.1016/j.canlet.2024.216807.
PubMed
Abstract available
Comprehensive analysis indicated that NDE1 is a potential biomarker for
pan-cancer and promotes bladder cancer progression.
Cancer Med. 2024;13:e6931.
PubMed
Abstract available
Circular STAG2 RNA Modulates Bladder Cancer Progression via miR-145-5p/TAGLN2 and
Is Considered as a Biomarker for Recurrence.
Cancers (Basel). 2024;16:978.
PubMed
Abstract available
Tumor Predisposing Post-Zygotic Chromosomal Alterations in Bladder
Cancer-Insights from Histologically Normal Urothelium.
Cancers (Basel). 2024;16:961.
PubMed
Abstract available
Effect of Clinical Complete Remission Following Neoadjuvant Pembrolizumab or
Chemotherapy in Bladder-Preservation Strategy in Patients with Muscle-Invasive
Bladder Cancer Declining Definitive Local Therapy.
Cancers (Basel). 2024;16:894.
PubMed
Abstract available
Membrane-associated RING-CH 7 inhibits stem-like capacities of bladder cancer
cells by interacting with nucleotide-binding oligomerization domain containing 1.
Cell Biosci. 2024;14:32.
PubMed
Abstract available
A first-in-class TIMM44 blocker inhibits bladder cancer cell growth.
Cell Death Dis. 2024;15:204.
PubMed
Abstract available
Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic
biomarker.
Cell Signal. 2024;117:111107.
PubMed
Abstract available
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract
Urothelial Carcinoma.
Clin Genitourin Cancer. 2024;22:27-37.
PubMed
Abstract available
The Role of Radical Cystectomy in Clinically Node Positive Bladder Cancer: A US
Veterans Health Administration Study.
Clin Genitourin Cancer. 2024 Feb 15:102055. doi: 10.1016/j.clgc.2024.
PubMed
Abstract available
Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With
Variant Histology Undergoing Radical Cystectomy.
Clin Genitourin Cancer. 2024;22:157-163.
PubMed
Abstract available
Sex Does Not Affect Survival: A Propensity Score-Matched Comparison in a
Homogenous Contemporary Radical Cystectomy Cohort.
Clin Genitourin Cancer. 2024;22:171-180.
PubMed
Abstract available
Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With
Metastatic Urothelial Carcinoma Requiring Treatment Interruption or
Discontinuation Due to Immune-Related Adverse Events.
Clin Genitourin Cancer. 2024;22:368-379.
PubMed
Abstract available
Prognostic Significance of Lymph Node Density in Pathological Node Positive
Urothelial Carcinoma of the Bladder -Upfront Surgery and Post Neoadjuvant
Chemotherapy Cohorts.
Clin Genitourin Cancer. 2024;22:385-393.
PubMed
Abstract available
Bladder-Preserving Trimodality Therapy With Capecitabine.
Clin Genitourin Cancer. 2024;22:476-482.
PubMed
Abstract available
Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert
Opinion.
Clin Genitourin Cancer. 2024;22:467-475.
PubMed
Abstract available
Comprehensive Evaluation of the Ability of Comorbidity and Health Status Indices
to Improve the Prediction of Perioperative Morbidity and Long-Term Survival
Outcomes After Radical Cystectomy.
Clin Genitourin Cancer. 2024;22:336-346.
PubMed
Abstract available
Circulating Basophils as a Prognostic Marker for Response to Bacillus
Calmette-Guerin.
Clin Genitourin Cancer. 2024;22:354-359.
PubMed
Abstract available
Prognostic Impact of the Modified 5-Item Frailty Index After Radical
Nephroureterectomy in Patients With Upper Tract Urothelial Carcinoma: A
Multicenter Retrospective Study.
Clin Genitourin Cancer. 2024;22:322-329.
PubMed
Abstract available
First-line Management of Metastatic Urothelial Cancer: Current and Future
Perspectives After the EV-302 and CheckMate-901 Studies.
Clin Genitourin Cancer. 2024;22:330-335.
PubMed
Abstract available
Central Nervous System Disease Progression Among Patients With Metastatic
Urothelial Carcinoma Treated With Enfortumab Vedotin: A Case Series.
Clin Genitourin Cancer. 2024;22:315-321.
PubMed
Bladder-sparing treatment using tislelizumab combined with gemcitabine/cisplatin
in selected patients with muscle-invasive bladder cancer: a real-world study.
Clin Transl Oncol. 2024 Mar 12. doi: 10.1007/s12094-024-03400.
PubMed
Abstract available
Literature analysis of cutaneous adverse reactions induced by tislelizumab.
Cutan Ocul Toxicol. 2024;43:52-57.
PubMed
Abstract available
Hypermethylation Loci of ZNF671, IRF8, and OTX1 as Potential Urine-Based
Predictive Biomarkers for Bladder Cancer.
Diagnostics (Basel). 2024;14:468.
PubMed
Abstract available
Urinary mutagenicity and bladder cancer risk in northern New England.
Environ Mol Mutagen. 2024 Mar 11. doi: 10.1002/em.22588.
PubMed
Abstract available
A first-in-class beta-glucuronidase responsive conjugate for selective dual targeted
and photodynamic therapy of bladder cancer.
Eur J Med Chem. 2024;269:116283.
PubMed
Abstract available
Assessing Long-term Treatment Benefits Using Complementary Statistical
Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214
Immune Checkpoint Inhibitor Trials.
Eur Urol. 2024;85:293-300.
PubMed
Abstract available
LEAP-011 in Urothelial Cancer. Unraveling the Puzzle: Combination or Cohort?
Eur Urol. 2024;85:239-241.
PubMed
Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and
Non-organ-confined Upper Tract Urothelial Carcinoma.
Eur Urol. 2024;85:283-292.
PubMed
Abstract available
Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with
Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind
Trial.
Eur Urol. 2024;85:229-238.
PubMed
Abstract available
Reply to Arnulf Stenzl, Morgan Roupret, J. Alfred Witjes, Paolo Gontero.
High-quality Transurethral Resection of Bladder Tumour Needs Additional Forms of
Tumour Delineation. Eur Urol 2023;83:193-4.
Eur Urol. 2024;85:309-312.
PubMed
Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing
Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the
Vesical Imaging-Reporting and Data System.
Eur Urol Focus. 2024;10:131-138.
PubMed
Abstract available
Survival of Patients with Chronic Kidney Disease Treated with Radical Cystectomy
and Risk Factors of Glomerular Filtration Rate Loss Following Radical Cystectomy:
Two Systematic Reviews and Meta-analyses of Interplay Between Radical Cystectomy
and Ren
Eur Urol Focus. 2024;10:169-181.
PubMed
Abstract available
Transcriptome-wide 1-methyladenosine functional profiling of messenger RNA and
long non-coding RNA in bladder cancer.
Front Genet. 2024;15:1333931.
PubMed
Abstract available
Oncopig bladder cancer cells recapitulate human bladder cancer treatment
responses in vitro.
Front Oncol. 2024;14:1323422.
PubMed
Abstract available
Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis.
Front Oncol. 2024;14:1303918.
PubMed
Abstract available
Prediction of Ki-67 expression in bladder cancer based on CT radiomics nomogram.
Front Oncol. 2024;14:1276526.
PubMed
Abstract available
Identification of RNA methylation-related lncRNAs for prognostic assessment and
immunotherapy in bladder cancer-based on single cell/Bulk RNA sequencing data.
Funct Integr Genomics. 2024;24:56.
PubMed
Abstract available
A plain language summary exploring a new treatment combination for untreated
locally advanced or metastatic urothelial cancer: enfortumab vedotin plus
pembrolizumab.
Future Oncol. 2024;20:351-360.
PubMed
Abstract available
Prognostic value of micrometric substaging in pT1 bladder cancer patients treated
with en-bloc transurethral resection.
Histopathology. 2024 Mar 13. doi: 10.1111/his.15177.
PubMed
Abstract available
Systemic versus localized Bacillus Calmette Guerin immunotherapy of bladder
cancer promotes an anti-tumoral microenvironment: Novel role of trained immunity.
Int J Cancer. 2024 Mar 14. doi: 10.1002/ijc.34897.
PubMed
Abstract available
Hyperoside induces cell cycle arrest and suppresses tumorigenesis in bladder
cancer through the interaction of EGFR-Ras and Fas signaling pathways.
Int J Med Sci. 2024;21:690-702.
PubMed
Abstract available
Incidence and predictors of intraoperative hypotension during transurethral
bladder tumor resection with oral 5-aminolevulinic acid.
Int J Urol. 2024;31:238-244.
PubMed
Abstract available
Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma
2023 by the Japanese Urological Association.
Int J Urol. 2024;31:194-207.
PubMed
Abstract available
Chronic kidney disease and Charlson comorbidity index predict complications after
robot-assisted radical cystectomy: A single-center study in Japan.
Int J Urol. 2024;31:231-237.
PubMed
Abstract available
The influence of the initial clinical presentation of upper tract urothelial
carcinoma on histopathological tumor features.
Int Urol Nephrol. 2024;56:1335-1341.
PubMed
Abstract available
Patients with periodontitis might increase the risk of urologic cancers: a
bidirectional two-sample Mendelian randomization study.
Int Urol Nephrol. 2024;56:1243-1251.
PubMed
Abstract available
Shame in patients undergoing ureterostomy: A cross-sectional survey.
Int Wound J. 2024;21:e14793.
PubMed
Abstract available
Utility of The Paris System (TPS) for upper urinary tract cytopathology:
correlation with histology follow-up and UroVysion fluorescence in situ
hybridization (FISH) analysis.
J Am Soc Cytopathol. 2024;13:149-155.
PubMed
Abstract available
A systematic review and meta-analysis of the anti-tumor effects of Paeoniae Radix
Rubra in animal models.
J Ethnopharmacol. 2024;326:117987.
PubMed
Abstract available
A Nomogram of MRI Features to Assess Muscle Invasion in VI-RADS 2 Tumors With
Stalk.
J Magn Reson Imaging. 2023 Aug 21. doi: 10.1002/jmri.28924.
PubMed
Abstract available
Editorial for "A Nomogram of MRI Features to Assess Muscle Invasion in VI-RADS 2
Tumors With Stalk".
J Magn Reson Imaging. 2023 Aug 9. doi: 10.1002/jmri.28922.
PubMed
Impact of Divergent Differentiation and/or Histological Subtype of Urothelial
Carcinoma on Patient Outcomes in the GETUG-AFU V05 VESPER Trial.
J Urol. 2024;211:564-574.
PubMed
Abstract available
Reason for euthanasia in dogs with urothelial carcinoma treated with chemotherapy
or radiation therapy or both: A retrospective observational study.
J Vet Intern Med. 2024;38:1127-1134.
PubMed
Abstract available
Reconstruction of a large scalp defect secondary to a rare cutaneous metastasis
from urothelial bladder carcinoma using intact fish skin xenografts.
J Wound Care. 2024;33.
PubMed
Latest evidence on clinical outcomes and prognostic factors of advanced
urothelial carcinoma in the era of immune checkpoint inhibitors: a narrative
review.
Jpn J Clin Oncol. 2024;54:254-264.
PubMed
Abstract available
Enfortumab vedotin following platinum-based chemotherapy and immune checkpoint
inhibitors for advanced urothelial carcinoma: response, survival and safety
analysis from a multicentre real-world Japanese cohort.
Jpn J Clin Oncol. 2024;54:329-338.
PubMed
Abstract available
TGFB1I1 promotes cell proliferation and migration in urothelial carcinoma.
Kaohsiung J Med Sci. 2024;40:269-279.
PubMed
Abstract available
[Multiple Pulmonary Metastases Seven Years After Transurethral Bladder Tumor
Resection for Non-muscle Invasion Bladder Cancer:Report of a Case].
Kyobu Geka. 2024;77:155-159.
PubMed
Abstract available
FGFR inhibitors in urothelial cancer: Contextualizing THOR within the new
treatment landscape.
Med. 2024;5:176-178.
PubMed
Abstract available
A prognostic risk prediction model based on ferroptosis-related long non-coding
RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation:
Erratum.
Medicine (Baltimore). 2024;103:e37547.
PubMed
Effectiveness of integrated nursing interventions in enhancing patient outcomes
during postoperative intravesical instillation for non-muscle invasive bladder
cancer: A comparative study.
Medicine (Baltimore). 2024;103:e36871.
PubMed
Abstract available
Establishment and validation of nomograms to predict the overall survival and
cancer-specific survival for non-metastatic bladder cancer patients: A large
population-based cohort study and external validation.
Medicine (Baltimore). 2024;103:e37492.
PubMed
Abstract available
Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by
up-regulating fatty acid transporter protein 2 and down-regulating
receptor-interacting protein kinase 3 in PMN-MDSCs.
Mol Cancer. 2024;23:52.
PubMed
Abstract available
Targeted Delivery of Catalase and Photosensitizer Ce6 by a Tumor-Specific Aptamer
Is Effective against Bladder Cancer In Vivo.
Mol Pharm. 2024 Mar 11. doi: 10.1021/acs.molpharmaceut.3c01047.
PubMed
Abstract available
Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and
Gemcitabine-Resistant Bladder Cancer Cells In Vitro.
Nutrients. 2024;16:623.
PubMed
Abstract available
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder
urothelial carcinoma.
Pathologica. 2024;116:55-61.
PubMed
Abstract available
A narrative review of management of muscle-invasive bladder cancer perioperative
period: will continuous and combined treatment be the new trend?
Transl Androl Urol. 2024;13:293-307.
PubMed
Abstract available
Understanding bladder cancer by genome-wide association studies.
Transl Androl Urol. 2024;13:363-365.
PubMed
Reliable prognostic definition and immunotherapy response prediction in bladder
cancer, based on a novel aging-associated 5-gene signature model.
Transl Androl Urol. 2024;13:193-208.
PubMed
Abstract available
Identification and verification of anoikis-related gene markers to predict the
prognosis of patients with bladder cancer and assist in the diagnosis and
treatment of bladder cancer.
Transl Cancer Res. 2024;13:579-593.
PubMed
Abstract available
Efficacy of the Addition of Robot-assisted Radical Cystectomy with Extracorporeal
Urinary Diversion after an Enhanced Recovery Protocol.
Urol J. 2024;21:40-46.
PubMed
Abstract available
Efficacy of cytoreductive radical cystectomy in metastatic urothelial bladder
cancer based on site and number of metastases.
Urol Oncol. 2024 Mar 12:S1078-1439(24)00337.
PubMed
Abstract available
Alignment of molecular subtypes across multiple bladder cancer subtyping
classifiers.
Urol Oncol. 2024 Mar 12:S1078-1439(24)00043.
PubMed
Abstract available
Reply to Khurshid R. Ghani's letter to editor regarding the article "Early
experience with UGN-101 for the treatment of upper tract urothelial cancer: a
multicenter evaluation of practice patterns and outcomes".
Urol Oncol. 2024;42:36.
PubMed
Prognostic impact of radiological tumor burden in patients with metastatic
urothelial carcinoma treated with pembrolizumab.
Urol Oncol. 2024;42:70.
PubMed
Abstract available
Survival impact of variant histology in patients with upper tract urothelial
carcinoma after radical nephroureterectomy.
Urol Oncol. 2024;42:69.
PubMed
Abstract available
Cost-Utility of Initial Management of High-grade T1 Bladder Cancer with
Intravesical BCG vs Immediate Radical Cystectomy.
Urology. 2024 Mar 9:S0090-4295(24)00126-2. doi: 10.1016/j.urology.2024.
PubMed
Abstract available
Perioperative chemotherapy in bladder cancer: the more cisplatin, the best
survival?
World J Urol. 2024;42:140.
PubMed
Thank you for your interest in scientific medicine.